Tag: R.I. Bio
Panelists: R.I. should build on life sciences momentum, foster interest in...
Between rapidly shifting tariffs, freezes to federal grant funding and changing U.S. Food and Drug Administration policies, R.I. Bio Director Glenn Robertelli acknowledges that...
PBN summit panelists: Blue tech, life sciences face ‘a pivotal point’
PROVIDENCE – While drivers battle rush hour traffic on the Washington Bridge, Flux Marine CEO Ben Sorkin’s commute is smooth sailing – almost literally.
Making...










